标题
Cabergoline in acromegaly
作者
关键词
Acromegaly, Cabergoline, Somatostatin analogues, Pegvisomant, Pituitary adenoma
出版物
Pituitary
Volume 20, Issue 1, Pages 121-128
出版商
Springer Nature
发表日期
2016-12-26
DOI
10.1007/s11102-016-0782-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study
- (2016) Manuel Puig-Domingo et al. Endocrinologia y Nutricion
- The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data
- (2015) Carmela Caputo et al. Lancet Diabetes & Endocrinology
- THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas
- (2014) Dominique Maiter et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
- (2014) Thomas J. Moore et al. JAMA Internal Medicine
- Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study
- (2013) Irina Bancos et al. CLINICAL ENDOCRINOLOGY
- Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas
- (2013) Renata S Auriemma et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
- (2013) Maya Barake et al. Pituitary
- No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
- (2012) Luigi Maione et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The changing face of acromegaly—advances in diagnosis and treatment
- (2012) Antônio Ribeiro-Oliveira Jr et al. Nature Reviews Endocrinology
- Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature
- (2012) Grace Lam et al. Neurosurgical Focus
- Pegvisomant and cabergoline combination therapy in acromegaly
- (2012) I. Bernabeu et al. Pituitary
- Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study
- (2011) Victoria Delgado et al. CLINICAL ENDOCRINOLOGY
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical therapy in acromegaly
- (2011) Mark Sherlock et al. Nature Reviews Endocrinology
- Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias?
- (2010) Haotian Gu et al. CLINICAL ENDOCRINOLOGY
- Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline
- (2010) M Lafeber et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly
- (2010) Priscilla Mattar et al. NEUROENDOCRINOLOGY
- Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR
- (2010) Lucio Vilar et al. Pituitary
- Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap
- (2010) B. Thakur et al. Pituitary
- Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma
- (2009) INTERNAL MEDICINE JOURNAL
- Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues
- (2009) M. Sherlock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide
- (2009) Raquel S. Jallad et al. NEUROENDOCRINOLOGY
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.
- (2008) Magnus Löndahl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- No Greater Incidence or Worsening of Cardiac Valve Regurgitation with Somatostatin Analog Treatment of Acromegaly
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search